© Copyright 2026 American Medical Association. All rights reserved.
The procedure described by CPT® Code 51715 involves the endoscopic injection of implant material into the submucosal tissues of the urethra and/or bladder neck. This intervention is specifically aimed at addressing mild incontinence, which can occur due to the thinning of tissues at the bladder outlet. The procedure utilizes a cystourethroscope, a specialized instrument that allows for direct visualization of the bladder outlet during the injection process. The physician carefully injects the implant material, which is typically collagen or a newer formulation that consists of a water-based gel containing carbon-coated beads. This material is strategically placed into the submucosal tissues surrounding the urethra and/or bladder neck to enhance tissue volume and support. By plumping up the bladder outlet tissues, the procedure aims to alleviate any laxity in the bladder outlet valve, thereby improving its function and reducing episodes of incontinence. It is important to note that achieving optimal results may require multiple injection sessions, often two to three, spaced over several weeks, to ensure adequate valve closure and effective management of incontinence symptoms.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.